IQVIA announces growth in customer engagement solution

The Orchestrated Customer Engagement Technology reportedly has been adopted by 140 life sciences companies (including top-10 pharma firms) in nearly 90.
IQVIA has announced its Orchestrated Customer Engagement (OCE) solution is now in use by 140 life-sciences companies located in 90 countries. The most recent to sign on, Laboratoires Thea, is an independent eye-care group in Europe.
The company reports its clients are leveraging OCE to accelerate their global digital transformation, in order to lead to more impactful interactions with customers. Customers now include AstraZeneca, Novo Nordisk, Roche, Adhera Therapeutics, Napo Pharmaceuticals, Pierre Fabre Pharmaceuticals, PruGen Pharmaceuticals, Recordati, Theramex and Zentiva.
Susan Hill, vice president and general manager of customer engagement with IQVIA, told Outsourcing-Pharma that the COVID-19 pandemic has created a need for accelerated digital adoption in pharma development firms.

Related Keywords

Susan Hill , Laboratoires Thea , Napo Pharmaceuticals , Astrazeneca , Prugen Pharmaceuticals , Pierre Fabre Pharmaceuticals , Novo Nordisk , Orchestrated Customer Engagement , Adhera Therapeutics , Clinical Development , Covid 19 , Clinical Evolution , Contract Manufacturing , Phasei Ii , Phase Iii Iv , Iqvia , Roche , Customer , Data Management , சூசன் மலை , நாபொ மருந்துகள் , பியர் ஃபேப்ரே மருந்துகள் , மருத்துவ வளர்ச்சி , மருத்துவ பரிணாமம் , ஒப்பந்த உற்பத்தி , கட்டம் ஈயீ இவ் , ரோச் , வாடிக்கையாளர் , தகவல்கள் மேலாண்மை ,